Home
|
Contact Us
|
Bookmark
HEPATITIS
HBV
HCV
HDV
CIRRHOSIS
HEPATIC ENCEPHALOPATHY (HE)
HEPATORENAL SYNDROME (HRS)
PRIMARY BILIARY CHOLANGITIS (PBC)
THROMBOCYTOPENIA
NASH
HCC
About CLDF
Board of Trustees
Board of Advisors/Faculty
2020 GI Fellow Board of Advisors
CLDF Committees
Centers of Educational Expertise
Live CME Events
Webcasts
Slide Library
Abstract Library
CLDF 2019 Year in Review
Conference Highlights
Industry
Available Topics
03-01-2019
Model finds bariatric surgery cost-effective in NASH
04-05-2016
FDA staff finds Intercept's liver drug effective as monotherapy
11-21-2014
Most heavy drinkers are not alcoholics, U.S. study finds
09-17-2014
Study shows downward trend in Sovaldi utilization
09-15-2014
Gilead to raise price for new hepatitis C drug above $84,000
08-13-2014
Vertex to end sales of hepatitis C drug telaprevir (Incivek)
06-20-2014
A 4-week hep C cure? Bristol to test drugs with Gilead's Sovaldi
05-01-2014
WellPoint's Obamacare business making a profit, so far
04-17-2014
UnitedHealth: New hepatitis C drug costs far more than forecast
04-10-2014
U.S. drug industry group defends price of Gilead hepatitis drug
03-21-2014
Gilead offers Egypt new hepatitis C drug at 99 percent discount
03-04-2014
Big Pharma pushes for U.S. action against India over patents
HEPATITIS
HBV
HCV
HDV
HCC
Slide Library
Abstract Library
HE
Webcasts
Slide Library
Abstract Library
HRS
Webcasts
Slide Library
Abstract Library
NASH
Webcasts
Slide Library
Abstract Library
PBC
Webcasts
Slide Library
Abstract Library
THROMBOCYTOPENIA
Webcasts
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
2019 GI Fellow Board of Advisors
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2021 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation
terms of use
and
privacy statement
.